Tumor angiogenesis in predicting the survival of patients with stage I lung cancer

被引:15
|
作者
Medetoglu, Baris [1 ]
Gunluoglu, Mehmet Zeki [1 ]
Demir, Adalet [1 ]
Melek, Huseyin [1 ]
Buyukpinarbasili, Nur [2 ]
Fener, Neslihan [2 ]
Dincer, Seyyit Ibrahim [1 ]
机构
[1] Yedikule Teaching Hosp Chest Dis & Thorac Surg, Dept Thorac Surg, Istanbul, Turkey
[2] Yedikule Teaching Hosp Chest Dis & Thorac Surg, Dept Pathol, Istanbul, Turkey
来源
关键词
ENDOTHELIAL GROWTH-FACTOR; PROGNOSTIC IMPACT; CD105; EXPRESSION; CARCINOMA; VEGF; METASTASIS; DENSITY; CD31;
D O I
10.1016/j.jtcvs.2010.07.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The effects of angiogenesis on survival were assessed by measuring the tumor microvessel density and vascular endothelial growth factor expression in patients with resected stage I non-small cell lung carcinoma. Methods: The study population included 141 patients who underwent complete resection for stage pT1 and T2 N0 M0 tumors between 1999 and 2007. Lobectomy and pneumonectomy were performed in 131 and 10 patients, respectively. Tumor specimens were analyzed immunohistochemically for staining with anti-CD105 antibody to determine tumor microvessel density and anti-vascular endothelial growth factor antibody to determine the vascular endothelial growth factor expression level. Univariate and multivariate analyses were performed for factors influencing patients' survival. Results: The overall 5-year survival was calculated as 68%, with rates of 76.9% for patients with T1 disease and 66.2% for patients with T2 disease (P = .4). The vascular endothelial growth factor expression rate was 94.3% for patients with stage I non-small cell lung carcinoma. Vascular endothelial growth factor expression did not influence survival (P = .9). The median microvessel density of the tumors measured based on the level of CD105 expression was 19.8. The effect of microvessel density on survival was significant (P = .02). The 5-year survivals of patients with tumors with 20 or more microvessels and less than 20 microvessels were 76.8% and 56.1%, respectively; this difference was highly significant (P = .004). The microvessel density was determined as an independent factor influencing survival on multivariate analysis (P = .03). Conclusions: The level of vascular endothelial growth factor expression in tumors was not a successful predictor of survival in patients with resected stage I non-small cell lung carcinoma. A high microvessel density based on CD105 is a strong predictor of prognosis in these patients. (J Thorac Cardiovasc Surg 2010;140:996-1000)
引用
收藏
页码:996 / 1000
页数:5
相关论文
共 50 条
  • [41] A highly expressed mRNA signature for predicting survival in patients with stage I/II non-small-cell lung cancer after operation
    Nan Ma
    Lu Si
    Meiling Yang
    Meihua Li
    Zhiyi He
    Scientific Reports, 11
  • [42] A highly expressed mRNA signature for predicting survival in patients with stage I/II non-small-cell lung cancer after operation
    Ma, Nan
    Si, Lu
    Yang, Meiling
    Li, Meihua
    He, Zhiyi
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [43] Do stage I lung cancer patients have lung cancer symptoms?
    Higgins, E. M.
    Rees, T.
    Lester, J. F.
    Davies, R. S.
    LUNG CANCER, 2016, 91 : S17 - S17
  • [44] Construction and evaluation of a nomogram for predicting survival in patients with lung cancer
    Ouyang, Jin
    Hu, Zhijian
    Tong, Jianlin
    Yang, Yong
    Wang, Juan
    Chen, Xi
    Luo, Ting
    Yu, Shiqun
    Wang, Xin
    Huang, Shaoxin
    AGING-US, 2022, 14 (06): : 2775 - 2792
  • [45] Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer - Discussion
    Miller, DL
    Harpole, DH
    Pass, HI
    ANNALS OF THORACIC SURGERY, 1996, 61 (05): : 1476 - 1476
  • [46] The cancer inflammation prognostic index is a valuable biomarker for predicting the survival of patients with stage I-III colorectal cancer
    Xie, Hailun
    Wei, Lishuang
    Liu, Mingxiang
    Liang, Yanren
    Wang, Qiwen
    Tang, Shuangyi
    Gan, Jialiang
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [47] Correlation of tumor size and survival in patients with stage IA non-small cell lung cancer
    Patz, EF
    Rossi, S
    Harpole, DH
    Herndon, JE
    Goodman, PC
    CHEST, 2000, 117 (06) : 1568 - 1571
  • [48] The Effect Of Statins On Survival In Patients With Stage Iv Lung Cancer
    Lin, J. J.
    Ezer, N.
    Sigel, K.
    Mhango, G.
    Wisnivesky, J. P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [49] Factors that affect the survival of patients with stage IV lung cancer
    Hussain, I.
    Khan, M.
    Shami, S.
    Ali, S.
    LUNG CANCER, 2018, 115 : S53 - S54
  • [50] The effect of statins on survival in patients with stage IV lung cancer
    Lin, Jenny J.
    Ezer, Nicole
    Sigel, Keith
    Mhango, Grace
    Wisnivesky, Juan P.
    LUNG CANCER, 2016, 99 : 137 - 142